Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2005 Aug;9(4):R323-30.
doi: 10.1186/cc3532. Epub 2005 May 13.

Time course of endothelial damage in septic shock: prediction of outcome

Affiliations
Clinical Trial

Time course of endothelial damage in septic shock: prediction of outcome

Ortrud Vargas Hein et al. Crit Care. 2005 Aug.

Abstract

Introduction: Endothelial damage accounts greatly for the high mortality in septic shock. Higher expression of mediators (IL-6, IL-8, soluble intercellular adhesion molecule 1 [sICAM-1], soluble endothelial-linked adhesion molecule 1 [sELAM-1]) have been described for non-survivors in comparison with survivors. We investigated the predictive value of the mediators IL-6, IL-8, sELAM-1 and sICAM-1 and their time course in intensive care unit patients who developed septic shock with respect to outcome.

Materials and methods: We measured serum levels of IL-6, IL-8, sELAM-1 and sICAM-1 in 40 intensive care unit patients who developed septic shock. Measurements were performed until death or until resolution of septic shock. Clinical and laboratory data were also recorded.

Results: After 48 hours the levels of sELAM-1 and sICAM-1 increased in non-survivors and decreased in survivors. sELAM-1 was predictive for outcome on the third day (P = 0.02) and the fourth day (P = 0.02) after diagnosis of septic shock. This difference in the time course between survivors and non-survivors occurred 7 days before death of the patients (median, 10 days). sICAM-1 levels increased significantly in non-survivors over the study period (P < 0.001). sELAM-1 (P = 0.04), IL-6 (P = 0.04) and IL-8 (P = 0.008) were significantly higher in non-survivors over the whole study period. The age and norepinephrine dose >0.5 mug/kg/min were significantly different between the groups.

Conclusion: sELAM-1 showed a markedly opposing course after 48 hours of septic shock. This adhesion molecule may be a useful early predictor of disease severity in the course of septic shock after early initial treatment of the patients, and might suggest considering endothelial-restoring therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
IL-6 for survivors and non-survivors over time.
Figure 2
Figure 2
IL-8 for survivors and non-survivors over time.
Figure 3
Figure 3
Soluble endothelial-linked adhesion molecule 1 (sELAM-1) for survivors and non-survivors over time. * Significant difference (P < 0.05) for sELAM-1 between survivors and non-survivors.
Figure 4
Figure 4
Soluble intercellular adhesion molecule 1 (sICAM-1) for survivors and non-survivors over time.

References

    1. Peters K, Unger RE, Brunner J, Kirkpatrick CJ. Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res. 2003;60:49–57. doi: 10.1016/S0008-6363(03)00397-3. - DOI - PubMed
    1. Reinhart K, Bayer O, Brunkhorst F, Meisner M. Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med. 2002;30:S302–S312. doi: 10.1097/00003246-200205001-00021. - DOI - PubMed
    1. Endo S, Inada K, Kasai T, Takakuwa T, Yamada Y, Koike S, Wakabayashi G, Niimi M, Taniguchi S, Yoshida M. Levels of soluble adhesion molecules and cytokines in patients with septic multiple organ failure. J Inflamm. 1995;46:212–219. - PubMed
    1. Ruokonen E, Parviainen I, Uusaro A. Treatment of impaired perfusion in septic shock. Ann Med. 2002;34:590–597. doi: 10.1080/078538902321117814. - DOI - PubMed
    1. Gogos CA, Lekkou A, Papageorgiou O, Siagris D, Skoutelis A, Bassaris HP. Clinical prognostic markers in patients with severe sepsis: a prospective analysis of 139 consecutive cases. J Infect. 2003;47:300–306. doi: 10.1016/S0163-4453(03)00101-4. - DOI - PubMed

Publication types

LinkOut - more resources